Leading Financial Service Provider in India | Canara Bank Securities Ltd

Fredun Pharmaceuticals Ltd.

Jun 06 BSE 728.95 ( -1.65 -0.23%)

Volume15965

Prev. Close
730.60

Open Price
736.00

Today's Low / High

721.00 739.80

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

635.00 955.50

Fredun Pharmaceuticals Ltd.is not traded in NSE

Market Cap. ( ₹ in Cr. )	344.19	P/BV	2.63	Book Value ( ₹ )	277.17
52 Week High/Low ( ₹ )	956/635	FV/ML	10/1	P/E(X)	16.54
Book Closure	30/09/2024	EPS ( ₹ )	44.07	Div Yield (%)	0.10

Standalone

(₹ in Crs.)

Particulars	Mar 25	Sep 24	Mar 24	Sep 23	Mar 23
Net Sales/Income from operations	267.28	184.43	203.87	142.71	157.37
Other Operating Income	0.00	0.00	0.82	0.00	0.00
Total Income From Operations	267.28	184.43	204.69	142.71	157.37

EXPENDITURE
Consumption of Raw Materials	197.67	124.90	167.37	116.39	152.15
Increase/Decrease in Stocks	-1.49	7.54	-13.96	-8.48	-35.71
Employees Cost	15.55	6.68	6.87	5.63	6.62
Depreciation	2.34	2.11	1.94	1.85	1.43
Other Expenses	27.72	22.60	23.07	13.28	15.76
Total Expenses	241.78	163.84	185.30	128.67	140.26

P/L Before Other Inc. , Int., Excpt. Items & Tax	25.50	20.58	19.39	14.04	17.11
Other Income	2.83	1.74	0.35	1.32	0.39
P/L Before Interest, Excpt. Items & Tax	28.33	22.32	19.74	15.36	17.50
Interest	13.15	9.22	8.14	5.51	5.51
P/L Before Exceptional Items & Tax	15.18	13.10	11.60	9.85	11.99
P/L Before Tax	15.18	13.10	11.60	9.85	11.99
Tax	2.77	4.69	2.32	3.51	5.28
P/L After Tax from Ordinary Activities	12.40	8.40	9.29	6.34	6.71
Net Profit/Loss For the Period	12.40	8.40	9.29	6.34	6.71

Equity Share Capital	4.72	4.72	4.70	4.68	4.53
Reserves And Surplus	0.00	0.00	0.00	0.00	91.84
EPS Before Extra Ordinary *
Basic EPS (Rs.)	26.27	17.80	19.76	13.56	14.80
Diluted EPS (Rs.)	26.27	17.80	19.77	13.56	14.81
EPS After Extra Ordinary *
Basic EPS (Rs.)	26.27	17.80	19.76	13.56	14.80
Diluted EPS (Rs.)	0.00	17.80	0.00	13.56	0.00

PBITOE Margin (%)	9.54	11.16	9.47	9.83	10.87
PBTE Margin (%)	5.67	7.10	5.66	6.90	7.61
PBT Margin (%)	5.67	7.10	5.66	6.90	7.61
PAT Margin (%)	4.64	4.55	4.53	4.44	4.26

Markets

Half yearly Results

HALF YEARLY RESULTS

Fredun Pharmaceuticals Ltd.